McGuire Investment Group LLC Decreases Stock Position in SPDR S&P Biotech ETF $XBI

McGuire Investment Group LLC reduced its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 93.0% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 8,306 shares of the exchange traded fund’s stock after selling 110,614 shares during the quarter. McGuire Investment Group LLC’s holdings in SPDR S&P Biotech ETF were worth $689,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also bought and sold shares of the company. Madrona Financial Services LLC purchased a new stake in SPDR S&P Biotech ETF in the second quarter worth $10,424,000. Meridian Investment Counsel Inc. boosted its holdings in shares of SPDR S&P Biotech ETF by 3.7% in the second quarter. Meridian Investment Counsel Inc. now owns 13,206 shares of the exchange traded fund’s stock worth $1,095,000 after acquiring an additional 470 shares during the period. Investment Partners Asset Management Inc. boosted its holdings in shares of SPDR S&P Biotech ETF by 4.0% in the second quarter. Investment Partners Asset Management Inc. now owns 3,257 shares of the exchange traded fund’s stock worth $270,000 after acquiring an additional 125 shares during the period. Perigon Wealth Management LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 39.7% in the second quarter. Perigon Wealth Management LLC now owns 6,720 shares of the exchange traded fund’s stock worth $557,000 after acquiring an additional 1,910 shares during the period. Finally, McAdam LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 5.1% in the second quarter. McAdam LLC now owns 3,273 shares of the exchange traded fund’s stock worth $271,000 after acquiring an additional 159 shares during the period.

SPDR S&P Biotech ETF Price Performance

SPDR S&P Biotech ETF stock opened at $101.39 on Thursday. SPDR S&P Biotech ETF has a one year low of $66.66 and a one year high of $105.47. The business has a fifty day moving average price of $91.48 and a 200-day moving average price of $84.95. The firm has a market capitalization of $5.52 billion, a P/E ratio of 11.47 and a beta of 0.97.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.